Literature DB >> 15197709

A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease.

Evelien Huisman1, Harry B M Uylings, Piet V Hoogland.   

Abstract

Hyposmia is one of the most prevalent symptoms of Parkinson's disease. It may occur even before the motor symptoms start. To determine whether the olfactory dysfunctions, like the motor symptoms, are associated with a loss of dopamine, the number of dopaminergic cells in the olfactory bulb of Parkinson's disease patients was studied using tyrosine hydroxylase immunohistochemistry. The quantitative analysis reveals that the total number of tyrosine hydroxylase-immunoreactive neurons in the olfactory bulb is twice as high in Parkinson patients compared to age and gender-matched controls. Because dopamine is known to inhibit olfactory transmission in the olfactory glomeruli, we suggest that the increase of dopaminergic neurons in the olfactory bulb is responsible for the hyposmia in Parkinson patients. The increase of dopamine in the olfactory bulb explains why olfaction does not improve with levodopa therapy. Copyright 2004 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197709     DOI: 10.1002/mds.10713

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  91 in total

Review 1.  Premotor Diagnosis of Parkinson's Disease.

Authors:  Heinz Reichmann
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

2.  Olfactory functions at the intersection between environmental exposure to manganese and Parkinsonism.

Authors:  Silvia Zoni; Giulia Bonetti; Roberto Lucchini
Journal:  J Trace Elem Med Biol       Date:  2012-06-02       Impact factor: 3.849

3.  Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia.

Authors:  Vidyulata Kamath; Paul J Moberg; Raquel E Gur; Richard L Doty; Bruce I Turetsky
Journal:  Behav Neurosci       Date:  2011-12-12       Impact factor: 1.912

4.  Adult human neurogenesis: from microscopy to magnetic resonance imaging.

Authors:  Amanda Sierra; Juan M Encinas; Mirjana Maletic-Savatic
Journal:  Front Neurosci       Date:  2011-04-04       Impact factor: 4.677

5.  Synaptic Regulator α-Synuclein in Dopaminergic Fibers Is Essentially Required for the Maintenance of Subependymal Neural Stem Cells.

Authors:  Ana Perez-Villalba; M Salomé Sirerol-Piquer; Germán Belenguer; Raúl Soriano-Cantón; Ana Belén Muñoz-Manchado; Javier Villadiego; Diana Alarcón-Arís; Federico N Soria; Benjamin Dehay; Erwan Bezard; Miquel Vila; Analía Bortolozzi; Juan José Toledo-Aral; Francisco Pérez-Sánchez; Isabel Fariñas
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

6.  Advanced time-series analysis of MEG data as a method to explore olfactory function in healthy controls and Parkinson's disease patients.

Authors:  Sanne Boesveldt; Cornelis J Stam; Dirk L Knol; Jeroen P A Verbunt; Henk W Berendse
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

7.  Osmophobia and olfactory functions in patients with migraine.

Authors:  Gürkan Kayabaşoglu; Aytug Altundag; Dilcan Kotan; Denizhan Dizdar; Recep Kaymaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-30       Impact factor: 2.503

Review 8.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

Review 9.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

Review 10.  Dual-transmitter neurons: functional implications of co-release and co-transmission.

Authors:  Christopher E Vaaga; Maria Borisovska; Gary L Westbrook
Journal:  Curr Opin Neurobiol       Date:  2014-05-13       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.